Supernus Pharmaceuticals Inc. (SUPN)
Market Closed
17 Jul, 20:00
$
48. 04
-0.17
-0.3526%
$
2.81B Market Cap
64.88 P/E Ratio
- Div Yield
439,400 Volume
2.16 Eps
$ 48.21
Previous Close 
Want to track SUPN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Supernus Pharmaceuticals Inc. (SUPN) Statistics
Valuation metrics
Market Cap 2.81B
Enterprise value 2.64B
Trailing P/E (ttm) -93.94
Forward P/E 11.73
PEG ratio 0.96
Price/Sales (ttm) 3.59
Price/Book (mrq) 2.57
Enterprise Value/Revenue 3.4
Enterprise Value/EBITDA 51.1
Overview
Shares outstanding 57.46M
Float 52.25M
Shares short 4.72M
% Held by insiders 0.04%
% Held by institutions 1.03%
Average volume (10 days) 408.44K
Average volume (90 days) 792.81K
Price summary
52-Week low 32.2
52-Week high 59.68
Beta 0.57
50-Day moving average 45.68
200-Day moving average 50.02
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.04%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.03%
Income Statement
Revenue (ttm) 776.83M
Revenue per share (ttm) 13.48
Quarterly revenue growth (yoy) 0.39%
Gross profit (ttm) 575.9M
EBITDA 67.95M
Net income to common (ttm) -29.02M
Diluted EPS (ttm) -0.5
Quarterly earnings growth (yoy) 0.21%
Balance Sheet
Total cash (mrq) 384.24M
Total cash per share (mrq) 6.67
Total debt (mrq) 40.9M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 1.96%
Book value per share (mrq) 18.68
Cash Flow
Cash flow statement 83.26M
Levered free cash flow (LFCF) 132.62M
